Chiayung Chu

1.5k total citations
19 papers, 1.1k citations indexed

About

Chiayung Chu is a scholar working on Infectious Diseases, Endocrinology and Immunology. According to data from OpenAlex, Chiayung Chu has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Endocrinology and 6 papers in Immunology. Recurrent topics in Chiayung Chu's work include Escherichia coli research studies (12 papers), Viral gastroenteritis research and epidemiology (11 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Chiayung Chu is often cited by papers focused on Escherichia coli research studies (12 papers), Viral gastroenteritis research and epidemiology (11 papers) and Clostridium difficile and Clostridium perfringens research (5 papers). Chiayung Chu collaborates with scholars based in United States, Israel and Cameroon. Chiayung Chu's co-authors include John B. Robbins, Rachel Schneerson, Joseph Shiloach, R. Schneerson, Shai Ashkenazi, D Bryla, J H Passwell, Shousun C. Szu, Ali Fattom and Nahid Farzam and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and Infection and Immunity.

In The Last Decade

Chiayung Chu

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiayung Chu United States 17 621 600 278 215 177 19 1.1k
Frederick J. Cassels United States 19 485 0.8× 429 0.7× 388 1.4× 162 0.8× 248 1.4× 37 1.2k
Nils Carlin Sweden 24 850 1.4× 665 1.1× 311 1.1× 202 0.9× 145 0.8× 38 1.2k
Cristina Alaimo Switzerland 16 356 0.6× 378 0.6× 346 1.2× 76 0.4× 70 0.4× 19 985
Raphael Simon United States 22 531 0.9× 668 1.1× 229 0.8× 700 3.3× 150 0.8× 60 1.4k
Joanna Kübler-Kiełb United States 23 245 0.4× 221 0.4× 492 1.8× 76 0.4× 230 1.3× 43 1.2k
João Ramos Costa Andrade Brazil 19 810 1.3× 555 0.9× 160 0.6× 346 1.6× 120 0.7× 32 1.1k
Dominique Schulz France 13 355 0.6× 468 0.8× 110 0.4× 488 2.3× 212 1.2× 19 1.0k
Renzo Alfini Italy 16 298 0.5× 298 0.5× 207 0.7× 188 0.9× 75 0.4× 41 831
Antoinette B. Hartman United States 20 776 1.2× 697 1.2× 217 0.8× 231 1.1× 364 2.1× 34 1.4k
Anders Kärnell Sweden 16 531 0.9× 553 0.9× 108 0.4× 175 0.8× 112 0.6× 22 881

Countries citing papers authored by Chiayung Chu

Since Specialization
Citations

This map shows the geographic impact of Chiayung Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiayung Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiayung Chu more than expected).

Fields of papers citing papers by Chiayung Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiayung Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiayung Chu. The network helps show where Chiayung Chu may publish in the future.

Co-authorship network of co-authors of Chiayung Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chiayung Chu. A scholar is included among the top collaborators of Chiayung Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiayung Chu. Chiayung Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Szu, Shousun C., et al.. (2014). Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine. Vaccine. 32(22). 2618–2622. 18 indexed citations
2.
Bellanti, Joseph A., Feng‐Ying C. Lin, Chiayung Chu, et al.. (2011). Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis. Clinical and Vaccine Immunology. 19(2). 140–145. 20 indexed citations
3.
Thiểm, Vũ Đình, Feng‐Ying C. Lin, Do Gia Canh, et al.. (2011). The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines. Clinical and Vaccine Immunology. 18(5). 730–735. 91 indexed citations
4.
Passwell, J H, Shai Ashkenazi, Nahid Farzam, et al.. (2010). Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children. Vaccine. 28(10). 2231–2235. 122 indexed citations
5.
Kübler-Kiełb, Joanna, Evgeny Vinogradov, Chiayung Chu, & Rachel Schneerson. (2006). O-Acetylation in the O-specific polysaccharide isolated from Shigella flexneri serotype 2a. Carbohydrate Research. 342(3-4). 643–647. 42 indexed citations
6.
Canh, Do Gia, Feng‐Ying C. Lin, Vũ Đình Thiểm, et al.. (2004). Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children. Infection and Immunity. 72(11). 6586–6588. 47 indexed citations
7.
Passwell, J H, Shai Ashkenazi, Dan Miron, et al.. (2003). Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-r EPAsucc conjugate vaccines in one- to four-year-old children. The Pediatric Infectious Disease Journal. 22(8). 701–706. 71 indexed citations
8.
Chu, Chiayung, et al.. (2003). Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in Mice. Infection and Immunity. 71(9). 5115–5120. 20 indexed citations
9.
Passwell, J H, Shai Ashkenazi, Chiayung Chu, et al.. (2001). Safety and Immunogenicity of ImprovedShigellaO-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel. Infection and Immunity. 69(3). 1351–1357. 95 indexed citations
11.
Pavliakova, Danka, Chiayung Chu, Slavomı́r Bystrický, et al.. (1999). Treatment with Succinic Anhydride Improves the Immunogenicity ofShigella flexneriType 2a O-Specific Polysaccharide–Protein Conjugates in Mice. Infection and Immunity. 67(10). 5526–5529. 19 indexed citations
12.
Pavliak, Viliam, Vince Pozsgay, Pavol Kováč, et al.. (1993). Binding of the O-antigen of Shigella dysenteriae type 1 and 26 related synthetic fragments to a monoclonal IgM antibody.. Journal of Biological Chemistry. 268(34). 25797–25802. 37 indexed citations
15.
Robbins, John B., Chiayung Chu, Douglas C. Watson, et al.. (1991). O-Specific Side-Chain Toxin-Protein Conjugates as Parenteral Vaccines for the Prevention of Shigellosis and Related Diseases. Clinical Infectious Diseases. 13(Supplement_4). S362–S365. 16 indexed citations
16.
Chu, Chiayung, et al.. (1991). Preparation, Characterization, andImmunogenicity ofConjugates ComposedoftheO-Specific Polysaccharide ofShigella dysenteriae Type1(Shiga's Bacillus) BoundtoTetanus Toxoid. 1 indexed citations
17.
Chu, Chiayung, Douglas C. Watson, D Bryla, et al.. (1991). Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infection and Immunity. 59(12). 4450–4458. 88 indexed citations
18.
Robbins, John B., Rachel Schneerson, Shousun C. Szu, et al.. (1989). Prevention of Invasive Bacterial Diseases by Immunization with Polysaccharide-Protein Conjugates. Current topics in microbiology and immunology. 169–180. 31 indexed citations
19.
Schneerson, Rachel, John E. Robbins, Chiayung Chu, et al.. (1982). Semi-Synthetic Vaccines Composed of Capsular Polysaccharides of Pathogenic Bacteria Covalently Bound to Proteins for the Prevention of Invasive Diseases. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 33. 144–158. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026